Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
N Engl J Med
; 389(16): 1453-1465, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851874
3.
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Oncologist
; 29(2): 142-150, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589219
4.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407342
5.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055304
6.
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.
Br J Cancer
; 126(1): 34-41, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671131
7.
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).
Br J Cancer
; 127(6): 1051-1060, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739300
8.
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1103-1115, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779531
9.
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.
BMC Cancer
; 21(1): 1238, 2021 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794412
10.
Advanced Penile Cancer Presenting With Renal Failure.
Oncology (Williston Park)
; 35(7): 425-428, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264567
11.
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
Br J Cancer
; 118(6): 793-801, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438372
12.
Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer.
BJU Int
; 121(2): 268-274, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940952
13.
Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence.
Clin Genitourin Cancer
; 22(1): 84-97, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101983
14.
Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials.
JACC CardioOncol
; 6(2): 267-279, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38774021
15.
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
J Clin Oncol
; 42(3): 312-323, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931206
16.
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma.
BMC Urol
; 13: 26, 2013 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688003
17.
Resilience of hospital and allied infrastructure during pandemic and post pandemic periods for maternal health care of pregnant women and infants in Tamil Nadu, India - A counterfactual analysis.
PLoS One
; 18(9): e0291749, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733715
18.
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK.
Curr Med Res Opin
; 39(3): 483-495, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629478
19.
Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 21(4): e242-e251, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922286
20.
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer.
NEJM Evid
; 2(12): EVIDoa2300251, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320501